Abstract
In particular, Article 14 of that Regulation specifies that for products authorised according to Article 9, an application for renewal shall be submitted in accordance with Article 7, at the latest one year before the expiry date of the authorisation.
The European Commission received a request from Lallemand SAS 2 for renewal of the authorisation of the product Levucell ® SC (Saccharomyces cerevisiae CNCM I-1077), when used as a feed additive for lambs (category: zootechnical additive; functional group: gut flora stabiliser) and horses (category: zootechnical additive; functional group: digestibility enhancers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 14(1) (renewal of an authorised feed additive). EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 28 May 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product Levucell ® SC (Saccharomyces cerevisiae CNCM I-1077), when used under the proposed conditions of use (see Section 3.1.3).
Interpretation of the Terms of Reference
The application for renewal of the authorisation does not include a proposal for amending or supplementing the conditions of the original authorisation that would have an impact on the efficacy of the additive; therefore, efficacy is not assessed. The present opinion will focus only on the safety aspects.
Additional information
The additive Levucell ® SC is a preparation of Saccharomyces cerevisiae CNCM I-1077. EFSA issued several opinions on the safety and efficacy of this product for the following species: dairy goats and dairy ewes (EFSA, 2006a; EFSA FEEDAP Panel, 2018) , leisure horses (EFSA, 2006b (EFSA, , 2009 , lambs for fattening (EFSA, 2008) , dairy cows, cattle for fattening, minor ruminant species and camelids (EFSA FEEDAP Panel, 2017 
2.
Data and methodologies
Data
The present assessment is based on data submitted by the applicant in the form of a technical dossier 7 in support of the request for the renewal of the authorisation for the use of Levucell ® SC (Saccharomyces cerevisiae CNCM I-1077) as a feed additive.
The European Union Reference Laboratory (EURL) considered that the conclusions and recommendations reached in the previous assessments are valid and applicable for the current application. 
Assessment
The additive is a preparation consisting of dried cells of S, cerevisiae (CNCM I-1077) intended for use as a zootechnical additive in feed for lambs (gut flora stabiliser) and horses (digestibility enhancer).
Characterisation 3.1.1. Characterisation of the additive
The product is authorised in two forms:
• Levucell ® SC20, a fine, granulated free-flowing powder with a minimal concentration of viable yeast cells of 2 9 10 10 colony forming units (CFU)/g of additive (granulated form), and
• Levucell ® SC10 ME (coated or microencapsulated form), with a minimal concentration of viable yeast cells of 1 9 10 10 CFU/g of additive.
The applicant is requesting the authorisation of a third form, Levucell ® SC10 ME Titan 10 11 For practical purposes, the two forms are considered equivalent. The applicant states that no changes in the manufacturing process or composition of the additive have been introduced since the authorisation (other than the production of the Titan form, see above). This was confirmed by the analysis of three batches of Levucell ® SC20 and SC10 forms produced in 2017, which showed compliance with specifications (2.6 9 10 10 -3.1 9 10 10 CFU/g and 1.5 9 10 10 -1.7 9 10 10 CFU/g for SC20 and SC10 ME, respectively).
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Data from three 2017 production batches of Levucell ® SC20 form and three of Levucell ® SC10 ME Titan were provided for microbiological purity.
12 Measurements for the Levucell ® SC20 form included aerobic bacteria (30-2.6 9 10 3 CFU/g), total coliforms (< 10 3 CFU/g), Escherichia coli (absent), Staphylococcus (absent) and Salmonella (absent in 25 g). For the Levucell ® SC10 ME Titan, values were provided for total bacteria (< 10 4 CFU/g), enterobacteria (< 10 2 CFU/g), E. coli (< 10 CFU/g) and Salmonella (absent in 25 g). 7 FEED dossier reference: FAD-2017-0069. 8 The reports linked to the previous dossiers are available on the EURL website: https://ec.europa.eu/jrc/en/eurl/feed-additives/ Chemical contamination was measured in two batches of Levucell ® SC20 produced in 2016 and one in 2017.
13 Data were provided for heavy metals (cadmium, mercury and lead < 0.05 mg/kg 14 ), arsenic (< 0.05, 0.064 and 0.10 mg/kg), aflatoxins (B1, B2, G1 and G2 < 1.0 lg/kg), ochratoxin A (< 0.2 lg/kg), zearalenone (< 5.0 lg/kg); dioxins (polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/F)) ≤ 0.0971 ng WHO-PCDD/F-TEQ/kg), the sum of dioxins and dioxin-like polychlorinated biphenyls ((DLPCBs) ≤ 0.0507 ng WHO-PCDD/F-DL-PCB-TEQ/kg) and non-DL-PCBs (≤ 0.0186 lg/kg). Other three batches of Levucell ® SC10 ME Titan 15 (one produced in 2016 and two in 2017) were analysed for arsenic (0.040, 0.014 and < 0.2 mg/kg), cadmium (0.0080, 0.014 and < 0.02 mg/kg), lead (0.012, 0.014 and < 0.02 mg/kg), mercury (< 0.0006 and < 0.1 mg/kg), aflatoxin B1 (< 0.10 lg/kg), dioxins (≤ 0.161 ng WHO-PCDD/F-TEQ/kg) and the sum of dioxins and dioxin-like polychlorinated biphenyls (≤ 0.274 ng WHO-PCDD/F-PCB-TEQ/kg). None of these values give rise to concerns.
Characterisation of the active agent
The active agent is a S. cerevisiae strain deposited at the National Culture Collection of Microorganisms (CNCM, France) with the accession number CNCM I-1077. 16 The strain is not genetically modified. 17 The strain was identified as S. cerevisiae by sequence analysis of the D1/D2 domains of the 26S rRNA gene.
18 Strain level identification is based on delta-polymerase chain reaction (PCR) and microsatellite genotyping of 13 loci.
Conditions of use
Levucell ® SC20 and Levucell ® SC10 ME are currently authorised at a minimum dose of 3.0 9 10 9 CFU/kg of complete feed for horses and lambs for fattening, with no maximum dose. For lambs the additive is recommended to be used at 7.3 9 10 9 CFU/kg of complete feedingstuffs. The applicant proposes to keep these conditions and to request the authorisation of Levucell ® SC10 ME Titan at the same conditions. Under other provisions the authorisation for horses foresees that:
• storage temperature, storage life and stability to pelleting are indicated in the directions for use of the additive and premixtures,
• the coated form is included only through a pelleted feed,
• safety glasses and masks are used for mixing if the mixers are not equipped with exhaust systems and if the product is handled or mixed in a confined atmosphere.
While that for lambs foresees that:
• 50°C are not exceeded with Levucell ® SC20 and 80°C with Levucell ® SC10 ME in complementary feedingstuffs,
• the coated form is included only through a pelleted feed.
Safety 3.2.1. Safety for the target species, consumers and the environment
The species S. cerevisiae is considered by EFSA to be suitable for the qualified presumption of safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2017) . This approach requires the identity of the strain to be conclusively established. In the view of the FEEDAP Panel, the identity of the strain S. cerevisiae (CNCM I-1077) was confirmed. Accordingly, this strain is considered by EFSA to be suitable for the QPS approach to safety and is presumed safe for the target species, consumers of products from animals fed the additive and the environment. Since no concerns are expected from other components of the additive, Levucell ® SC is also considered safe for the target species, consumers of products from animals fed the additive and the environment.
Safety for the user
In a previous opinion, the FEEDAP Panel concluded that Levucell ® SC is not a dermal irritant or sensitiser but is an eye irritant. Inhalation exposure is unlikely. Encapsulation is not expected to introduce hazards for users (EFSA FEEDAP Panel, 2017) .
Further evidence of safety
The applicant states that no adverse effects or specific interactions or incompatibilities have been reported for the additive.
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The applicant conducted a literature search on the safety of Levucell ® SC using several databases: CAB Abstracts, Agris, Scopus, Google Scholar, Bielefeld Academic Search Engine (BASE) and the Li ege University library. 19 The search included the terms: CNCM I-1077, Levucell SC, Saccharomyces cerevisiae, safe*, tox*, tolerance, adverse effects, epidemiology, feed, incompatib* and interact*. The search covered the period 2006-2018. The search identified 74 relevant publications (Appendix A). None was designed to assess the safety per se of the additive, but the use of Levucell ® SC in farm animals (ruminants and/or horses). However, the studies were mostly designed to observe the effect of the additive on zootechnical performance and included some health parameters (i.e. blood biochemistry). None of these studies reported safety issues with the additive under assessment.
Therefore, the FEEDAP Panel concludes that there is no new evidence that would lead the Panel to reconsider its previous conclusions on the safety of the product for target species, consumers and the environment under the authorised conditions of use.
3.3.
Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market monitoring plan other than those established in the Feed Hygiene Regulation 20 and Good Manufacturing Practice.
Conclusions
The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation.
The FEEDAP Panel confirms its previous conclusion that Levucell ® SC is safe for the target species, consumers of products from animals fed the additive, users and the environment. Levucell ® SC is an eye irritant. z taka lakiu z ju z riebalu z r ug s ciu z koncentracijai ir bakteriju z skai ciui karviu z did ziojo prieskrand zio turinyje. Veterinarija ir Zootechnika, 57, 77.
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